A detailed history of Leo Brokerage, LLC transactions in Immuno Gen, Inc. stock. As of the latest transaction made, Leo Brokerage, LLC holds 25,000 shares of IMGN stock, worth $0. This represents 0.05% of its overall portfolio holdings.

Number of Shares
25,000
Previous 25,000 -0.0%
Holding current value
$0
Previous $96,000 390.63%
% of portfolio
0.05%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

BUY
$3.67 - $4.92 $91,750 - $123,000
25,000 New
25,000 $96,000
Q2 2022

Jul 11, 2022

SELL
$3.15 - $5.76 $78,750 - $144,000
-25,000 Closed
0 $0
Q1 2022

May 03, 2022

BUY
$4.26 - $7.48 $106,500 - $187,000
25,000 New
25,000 $119,000

Others Institutions Holding IMGN

About ImmunoGen, Inc.


  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Leo Brokerage, LLC Portfolio

Follow Leo Brokerage, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Leo Brokerage, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Leo Brokerage, LLC with notifications on news.